Page last updated: 2024-10-15

diaminoglyoxime

Description

diaminoglyoxime: a ballistic modifier in RDX incorporated double base propellant formulations; DAG does not have adverse effect on vulnerability and chemical stability of the propellant formulation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135449698
MeSH IDM0495018

Synonyms (10)

Synonym
2580-79-2
diaminoglyoxime
FT-0624615
AKOS030659819
BCP30485
oxalamide oxime;diaminoglyoxime; oxamide dioxime; n,n-dihydroxyoxalamidine; 2,6-dibromo-4-tolylhydrazine hydrochloride; 1,2-diamino-1,2-ethanedione dioxime
ethanediimidamide, n,n''-dihydroxy-
DTXSID20878687
cid 135449698
mfcd00463937
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]